Details for New Drug Application (NDA): 202511
✉ Email this page to a colleague
The generic ingredient in SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE is magnesium sulfate; potassium sulfate; sodium sulfate. There are one hundred and forty-six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the magnesium sulfate; potassium sulfate; sodium sulfate profile page.
Summary for 202511
Tradename: | SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE |
Applicant: | Novel Labs Inc |
Ingredient: | magnesium sulfate; potassium sulfate; sodium sulfate |
Patents: | 0 |
Suppliers and Packaging for NDA: 202511
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE | magnesium sulfate; potassium sulfate; sodium sulfate | SOLUTION;ORAL | 202511 | ANDA | Novel Laboratories, Inc. | 40032-700 | 40032-700-83 | 2 BOTTLE in 1 CARTON (40032-700-83) / 177 mL in 1 BOTTLE |
SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE | magnesium sulfate; potassium sulfate; sodium sulfate | SOLUTION;ORAL | 202511 | ANDA | Lupin Pharmaceuticals, Inc. | 43386-700 | 43386-700-02 | 1 BOTTLE in 1 CONTAINER (43386-700-02) / 177 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;ORAL | Strength | 1.6GM/BOT;3.13GM/BOT;17.5GM/BOT | ||||
Approval Date: | Feb 23, 2017 | TE: | AA | RLD: | No |
Complete Access Available with Subscription